https://www.marketshost.com/ai-score/us/tvtx
TVTX Stock Analysis 2026: HOLD Rating (68%) | Travere Therapeutics, Inc.
May 16, 2026 - TVTX stock: HOLD rating (68% confidence). Travere Therapeutics, Inc. fundamental analysis 2026. Revenue: $127.2M. EPS: $-0.40. ROE: -37.6%.
stock analysistvtxholdratingtherapeutics